In summary, deleting the four cysteines of the N-terminus of TC-2 improved recombinant production by preventing aggregation without abrogating its ability to inhibit T. vaginalis CPs, suggesting that rTC-2Δ11 has potential therapeutic applications against trichomoniasis. The gene discussed is CAD; the disease is Trichomonas vaginitis urogenital infection.